C-MER Medical repurchases shares, increasing treasury holdings

C-MER Medical Holdings Limited, an equity issuer, submitted its Next Day Disclosure Return on November 12, 2025, detailing recent changes in its share capital. The company repurchased 200,000 ordinary shares on the Exchange on November 12, 2025, at a price ranging from HK$1.8 to HK$1.82 per share, with an aggregate price paid of HK$362,860. These repurchased shares are being held as treasury shares.

Following this repurchase, the company's issued shares (excluding treasury shares) decreased to 1,239,832,870 from an opening balance of 1,240,032,870. The number of treasury shares increased to 15,728,000 from 15,528,000.

The company also disclosed that it is authorized to repurchase up to 125,556,087 shares under a mandate granted on May 19, 2025. The 200,000 shares repurchased represent 0.0161% of the issued shares (excluding treasury shares) as of the mandate date. A moratorium period for new share issues or sales of treasury shares is in effect until December 12, 2025.